Commentary
In their review, Y. Ando and J. H. Jou (Oregon Health & Science University Hospital, Portland, Oregon, USA) summaries updated guideline and guidance recommendations for the management of adult NAFLD. They highlight key difference between US, Asian, and European recommendations; and provide key updates.
– American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (Hepatology 2012;55:2005‐2023).
– AASLD: Hepatology 2018;67:328‐357.
– EASL‐EASD‐EASO: J Hepatol 2016;64:1388‐1402.
– Asia‐Pacific: J Gastroenterol Hepatol 2018;33:70‐85 & J Gastroenterol Hepatol 2018;33:86‐98.
Previous Post
Is Europe ready to meet the challenge of fatty liver disease?
Next Post
Liver injury in COVID-19